These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 2888621)

  • 21. Monooxygenase-mediated activation of chlorotrianisene (TACE) in covalent binding to rat hepatic microsomal proteins.
    Juedes MJ; Bulger WH; Kupfer D
    Drug Metab Dispos; 1987; 15(6):786-93. PubMed ID: 2893703
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition and induction of rabbit liver microsomal cytochrome P-450 by pyridine.
    Kaul KL; Novak RF
    J Pharmacol Exp Ther; 1987 Oct; 243(1):384-90. PubMed ID: 3668864
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of morphine on the responses to and disposition of phencyclidine in mice. I. Enhancement of phencyclidine effects by acute morphine administration.
    Nabeshima T; Sivam SP; Ho IK
    J Pharmacol Exp Ther; 1983 May; 225(2):325-31. PubMed ID: 6842396
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Practolol metabolism. III. Irreversible binding of [14C]practolol metabolite(s) to mammalian liver microsomes.
    Orton TC; Lowery C
    J Pharmacol Exp Ther; 1981 Oct; 219(1):207-12. PubMed ID: 6793710
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Metabolism of spironolactone by adrenocortical and hepatic microsomes: relationship to cytochrome P-450 destruction.
    Sherry JH; O'Donnell JP; Flowers L; Lacagnin LB; Colby HD
    J Pharmacol Exp Ther; 1986 Mar; 236(3):675-80. PubMed ID: 3950869
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vitro studies on the metabolic activation of the furanopyridine L-754,394, a highly potent and selective mechanism-based inhibitor of cytochrome P450 3A4.
    Sahali-Sahly Y; Balani SK; Lin JH; Baillie TA
    Chem Res Toxicol; 1996 Sep; 9(6):1007-12. PubMed ID: 8870989
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Selective pathways for the metabolism of phencyclidine by cytochrome p450 2b enzymes: identification of electrophilic metabolites, glutathione, and N-acetyl cysteine adducts.
    Shebley M; Jushchyshyn MI; Hollenberg PF
    Drug Metab Dispos; 2006 Mar; 34(3):375-83. PubMed ID: 16326815
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fate of isopropyl-iodoamphetamine (IMP) in rat liver microsomes.
    Joulin Y; Moretti JL; Hoellinger H; Defer G
    Nucl Med Commun; 1992 Feb; 13(2):99-105. PubMed ID: 1436904
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vitro biotransformation of 1,1-dichloroethylene by hepatic cytochrome P-450 2E1 in mice.
    Lee RP; Forkert PG
    J Pharmacol Exp Ther; 1994 Jul; 270(1):371-6. PubMed ID: 8035334
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Application of chemical cytochrome P-450 model systems to studies on drug metabolism. IV. Mechanism of piperidine metabolism pathways via an iminium intermediate.
    Masumoto H; Ohta S; Hirobe M
    Drug Metab Dispos; 1991; 19(4):768-80. PubMed ID: 1680654
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Covalent binding of a reactive metabolite derived from propranolol and its active metabolite 4-hydroxypropranolol to hepatic microsomal proteins of the rat.
    Narimatsu S; Arai T; Watanabe T; Masubuchi Y; Horie T; Suzuki T; Ishikawa T; Tsutsui M; Kumagai Y; Cho AK
    Chem Res Toxicol; 1997 Mar; 10(3):289-95. PubMed ID: 9084908
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mechanism-based inhibition of cytochrome P-450 by heterocyclic analogues of phencyclidine.
    Brady JF; Dokko J; Di Stefano EW; Cho AK
    Drug Metab Dispos; 1987; 15(5):648-52. PubMed ID: 2891481
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mechanism-based inactivation of rat liver cytochrome P-450 2B1 by 2-methoxy-5-nitrobenzyl bromide.
    Armstrong AP; Hollenberg PF
    Drug Metab Dispos; 1999 Jun; 27(6):741-5. PubMed ID: 10348806
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Metabolism and binding of cyclophosphamide and its metabolite acrolein to rat hepatic microsomal cytochrome P-450.
    Marinello AJ; Bansal SK; Paul B; Koser PL; Love J; Struck RF; Gurtoo HL
    Cancer Res; 1984 Oct; 44(10):4615-21. PubMed ID: 6380709
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Denitrosation of the anti-cancer drug 1,3-bis(2-chloroethyl)-1-nitrosourea catalyzed by microsomal glutathione S-transferase and cytochrome P450 monooxygenases.
    Weber GF; Waxman DJ
    Arch Biochem Biophys; 1993 Dec; 307(2):369-78. PubMed ID: 8274024
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Aryl acetylenes as mechanism-based inhibitors of cytochrome P450-dependent monooxygenase enzymes.
    Foroozesh M; Primrose G; Guo Z; Bell LC; Alworth WL; Guengerich FP
    Chem Res Toxicol; 1997 Jan; 10(1):91-102. PubMed ID: 9074808
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mutation of a single residue (K262R) in P450 2B6 leads to loss of mechanism-based inactivation by phencyclidine.
    Shebley M; Hollenberg PF
    Drug Metab Dispos; 2007 Aug; 35(8):1365-71. PubMed ID: 17460030
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inactivation of constitutive hepatic cytochromes P450 by phencyclidine in the rat.
    Hiratsuka A; Chu TY; Distefano EW; Lin LY; Schmitz DA; Cho AK
    Drug Metab Dispos; 1995 Feb; 23(2):201-6. PubMed ID: 7736912
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Metabolism of N-nitroso-2,6-dimethylmorpholine by isozymes of rabbit liver microsomal cytochrome P-450.
    Kokkinakis DM; Koop DR; Scarpelli DG; Coon MJ; Hollenberg PF
    Cancer Res; 1985 Feb; 45(2):619-24. PubMed ID: 3967237
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Selective inactivation by chloramphenicol of the major phenobarbital-inducible isozyme of dog liver cytochrome P-450.
    Ciaccio PJ; Duignan DB; Halpert JR
    Drug Metab Dispos; 1987; 15(6):852-6. PubMed ID: 2893713
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.